Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
Ambrx Biopharma Total Assets (Quarterly): 271.50M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 271.50M |
| June 30, 2023 | 279.94M |
| March 31, 2023 | 210.61M |
| December 31, 2022 | 146.98M |
| June 30, 2022 | 180.87M |
| Date | Value |
|---|---|
| December 31, 2021 | 229.02M |
| June 30, 2021 | 213.72M |
| June 30, 2021 | 213.72M |
| December 31, 2020 | 134.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
134.02M
Minimum
Dec 2020
279.94M
Maximum
Jun 2023
208.93M
Average
213.72M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 178.29B |
| Axonics Inc | 774.17M |
| Harpoon Therapeutics Inc (DELISTED) | 47.58M |
| Merck & Co Inc | 117.53B |
| RayzeBio inc (DELISTED) | 603.51M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.10M |
| Shareholders Equity (Quarterly) | 242.40M |
| Current Ratio | 12.80 |